within Pharmacolibrary.Drugs.ATC.G;

model G02BB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.56,
    Cl             = 0.058333333333333334,
    adminDuration  = 600,
    adminMass      = 0.011699999999999999,
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>The vaginal ring containing progestogen and estrogen is a contraceptive device designed for intravaginal administration delivering a combination of an estrogen (usually ethinylestradiol) and a progestogen (such as etonogestrel). It provides effective reversible contraception and is approved for use by women of reproductive age.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical healthy adult female user, as reported for the etonogestrel/ethinylestradiol vaginal ring (e.g., NuvaRing).</p><h4>References</h4><ol><li><p>Kerns, J, &amp; Darney, P (2011). Vaginal ring contraception. <i>Contraception</i> 83(2) 107–115. DOI:<a href=&quot;https://doi.org/10.1016/j.contraception.2010.07.008&quot;>10.1016/j.contraception.2010.07.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21237335/&quot;>https://pubmed.ncbi.nlm.nih.gov/21237335</a></p></li><li><p>de Jesus Antunes, N, et al., &amp; De Nucci, G (2021). Single-dose pharmacokinetics and pharmacodynamics assessment of oestriol and trimegestone containing vaginal rings in healthy women with childbearing potential. <i>The European journal of contraception &amp; reproductive health care : the official journal of the European Society of Contraception</i> 26(3) 184–194. DOI:<a href=&quot;https://doi.org/10.1080/13625187.2021.1884219&quot;>10.1080/13625187.2021.1884219</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33645377/&quot;>https://pubmed.ncbi.nlm.nih.gov/33645377</a></p></li><li><p>Weiss, H, et al., &amp; Friend, DR (2019). Pharmacokinetics and Tolerability of a Novel 17β-Estradiol and Progesterone Intravaginal Ring in Sheep. <i>Journal of pharmaceutical sciences</i> 108(8) 2677–2684. DOI:<a href=&quot;https://doi.org/10.1016/j.xphs.2019.03.032&quot;>10.1016/j.xphs.2019.03.032</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30959058/&quot;>https://pubmed.ncbi.nlm.nih.gov/30959058</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G02BB01;
